Li CG - Search Results

1

Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer.

Xin R, Shen B, Huang ZY, Liu JB, Li S, Jiang GX, Zhang J, Cao YH, Zou DZ, Li W, Li CG, Ma YS, Fu D. Xin R, et al. Among authors: li s, li cg, li w. Curr Pharm Biotechnol. 2023;24(3):427-437. doi: 10.2174/1389201023666220818085945. Curr Pharm Biotechnol. 2023. PMID: 35984029 Review.

2

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.

Liang Z, Kong R, He Z, Lin LY, Qin SS, Chen CY, Xie ZQ, Yu F, Sun GQ, Li CG, Fu D, Jiang GX, Chen J, Ma YS. Liang Z, et al. Among authors: li cg. Oncotarget. 2017 Jul 18;8(29):47389-47399. doi: 10.18632/oncotarget.17650. Oncotarget. 2017. PMID: 28537888 Free PMC article.

3

Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.

Yin YZ, Yao SH, Li CG, Ma YS, Kang ZJ, Zhang JJ, Jia CY, Hou LK, Qin SS, Fan X, Zhang H, Yang MD, Zhang DD, Lu GX, Wang HM, Gu LP, Tian LL, Wang PY, Cao PS, Wu W, Cao ZY, Lv ZW, Shi BW, Wu CY, Jiang GX, Fu D, Yu F. Yin YZ, et al. Among authors: li cg. Am J Transl Res. 2021 Jan 15;13(1):168-182. eCollection 2021. Am J Transl Res. 2021. PMID: 33527016 Free PMC article.

4

HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway.

Wang X, Shi B, Zhao Y, Lu Q, Fei X, Lu C, Li C, Chen H. Wang X, et al. Cancer Cell Int. 2020 Sep 12;20:450. doi: 10.1186/s12935-020-01539-7. eCollection 2020. Cancer Cell Int. 2020. PMID: 32943998 Free PMC article.

5

Elevated tumor markers in a benign lung disease.

Chen Q, Lu Q, Fei X, Li C, Li B. Chen Q, et al. J Cardiothorac Surg. 2021 Oct 18;16(1):308. doi: 10.1186/s13019-021-01688-4. J Cardiothorac Surg. 2021. PMID: 34663400 Free PMC article.

6

ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2.

Xu L, Liao WL, Lu QJ, Li CG, Yuan Y, Xu ZY, Huang SD, Chen HZ. Xu L, et al. Among authors: li cg. J Cancer. 2016 Apr 28;7(7):862-71. doi: 10.7150/jca.14440. eCollection 2016. J Cancer. 2016. PMID: 27162546 Free PMC article.

7

Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelial‑mesenchymal transition.

Xu L, Yan Y, Xue X, Li CG, Xu ZY, Chen HZ. Xu L, et al. Among authors: li cg. Oncol Rep. 2016 Nov;36(5):2836-2842. doi: 10.3892/or.2016.5107. Epub 2016 Sep 19. Oncol Rep. 2016. PMID: 27667357

8

MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway.

Wang X, Zhao Y, Lu Q, Fei X, Lu C, Li C, Chen H. Wang X, et al. J Cancer. 2020 Mar 4;11(10):3072-3081. doi: 10.7150/jca.39861. eCollection 2020. J Cancer. 2020. PMID: 32226522 Free PMC article.

9

LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma.

Wang X, Zhao Y, Fei X, Lu Q, Li Y, Yuan Y, Lu C, Li C, Chen H. Wang X, et al. Int J Biol Sci. 2020 Jun 29;16(13):2392-2404. doi: 10.7150/ijbs.47035. eCollection 2020. Int J Biol Sci. 2020. PMID: 32760207 Free PMC article.

10

TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway.

Zhu M, Shi B, Li C, Xu S. Zhu M, et al. Open Med (Wars). 2022 Dec 2;17(1):1883-1895. doi: 10.1515/med-2022-0601. eCollection 2022. Open Med (Wars). 2022. PMID: 36518116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page